GlassScriptPhysician profile
Gary L Timmerman
NPI 1326095332
$308.14
in general payments reported to CMS, 2019-2025
14 companies · $88.48 in 2025
The $88.48 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $16.41 · 2023: $14.68 · 2024: $42.30 · 2025: $88.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $145.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $74.47 | 2019 | |
| Conmed Corporation | $33.00 | 2025 | |
| Tela Bio, INC. | $24.98 | 2024 | Ovitex 2s |
| C. R. Bard, INC. & Subsidiaries | $22.00 | 2025 | Bard Urinary Drainage Bag |
| Allergan, INC. | $19.81 | 2019 | |
| Integra Lifesciences Corporation | $18.86 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Teleflex LLC | $17.32 | 2024 | Titan Sgs |
| Mallinckrodt Hospital Products INC. | $16.41 | 2020 | |
| Mallinckrodt Enterprises LLC | $15.07 | 2019 | |
| Innovation Technologies INC | $14.68 | 2023 | Irrisept |
| Kerecis Limited | $14.62 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Acell, INC. | $14.18 | 2019 | |
| Merck Sharp & Dohme LLC | $11.38 | 2019 | |
| Shire North American Group INC | $11.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Timmerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.